Provectus Pharmaceuticals, Inc. (NASDAQOTCBB:PVCT.OB)

CAPS Rating 1 out of 5 
PVCT.OB VS S&P 500 (SPY)

PVCT.OB News and Commentary

Related News and Articles

How do you think PVCT.OB will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

12 Outperform
14 Underperform
 

All-Star Players

4 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top PVCT.OB Bull/Bear Pitches

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Fools bullish on PVCT.OB
are also bullish on:

NeroSagetrade (91.74)
Submitted October 03, 2007

Wow....seriously wow.... $288 in full year revenues...thats not in billions, millions, tens or even thousands. Thats $288 DOLLARS in full year revenues. They have ONE...yes, ONE drug in mid-phase trials, are producing 4-5 million in yearly losses and… More

Featured Broker Partners


Advertisement